MedPath

PROCAINAMIDE HYDROCHLORIDE

PROCAINAMIDE HYDROCHLORIDE INJ, USP 100MG/ML 10ML SYR

Approved
Approval ID

fece65c0-fdbc-61d8-e053-6294a90a9a68

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 22, 2024

Manufacturers
FDA

HF Acquisition Co LLC, DBA HealthFirst

DUNS: 045657305

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PROCAINAMIDE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51662-1630
Application NumberANDA088636
Product Classification
M
Marketing Category
C73584
G
Generic Name
PROCAINAMIDE HYDROCHLORIDE
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateJanuary 22, 2024
FDA Product Classification

INGREDIENTS (5)

SODIUM BISULFITEInactive
Quantity: 0.09 mg in 1 mL
Code: TZX5469Z6I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
PROCAINAMIDE HYDROCHLORIDEActive
Quantity: 100 mg in 1 mL
Code: SI4064O0LX
Classification: ACTIB
BENZYL ALCOHOLInactive
Quantity: 0.9 mg in 1 mL
Code: LKG8494WBH
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PROCAINAMIDE HYDROCHLORIDE - FDA Drug Approval Details